Stable olanzapine tablets comprising compacted blend of olanzapine and at least one pharmaceutical excipient; mixed with extragranular blend of diluent(s). disintegrant(s). Iubricant(s) and sweetener(s), wherein the said tablets are stable to color, chemical degradation and polymorphic changes for atleast 3 months a...
A sustained release oral composition of an antipsychotic agent comprising antipsychotic agent. carragccnan arid one or more pharmaceuiically acceptable excipients; wherein the antipsychotic agent is 2-[2-(4-dibenzo {b,f}[l,4-thiazepin-l lyi -l-piperazinyl)ethoxy ethanol] or its pharmaccutically acceptable salt.
...
An oral pharmaceutical composition of dutasteride or its pharmaceutically acceptable salt comprising admixture of
a) dutasteride or its pharmaceutically acceptable salt;
b) one or more surfactant (s) /co-surfactant(s);
c) one or more oil (s);
d) optionally antioxidant (s); and
e) optionally excipient (s);
wher...
A stable pharmaceutical composition comprising fesoterodine hydrochloride, a rate controlling polymer sugar alcohol and at least one pharmaceutical excipient(s) and the process of its preparation.
Documents
Form AOC-4-12112016_signed
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-10112016
Directors report as per section 134(3)-10112016
List of share holders, debenture holders;-07112016
Form MGT-7-07112016
Form MGT-7-180216.OCT
Form AOC-4-170216.OCT
Form MGT-14-090315.OCT
Copy of resolution-090315.PDF
Form23AC-130215 for the FY ending on-310314.OCT
FormSchV-241214 for the FY ending on-310314.OCT
Form GNL.2-271114.OCT
Form PAS-3-221114.OCT
Resltn passed by the BOD-211114.PDF
List of allottees-211114.PDF
Optional Attachment 1-131014.PDF
Form MGT-14-140814.OCT
Copy of resolution-070814.PDF
Form PAS-3-200514.OCT
Copy of the special resolution authorizing the issue of securities-200514.PDF